BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $970,803 | -23.3% | 40,366 | +1.9% | 0.00% | -50.0% |
| Q2 2023 | $1,264,907 | -53.2% | 39,615 | -55.2% | 0.00% | -33.3% |
| Q1 2023 | $2,705,338 | -21.8% | 88,352 | -0.1% | 0.00% | -40.0% |
| Q4 2022 | $3,458,966 | -17.3% | 88,442 | +0.8% | 0.01% | -16.7% |
| Q3 2022 | $4,180,124 | +45.0% | 87,744 | +17.8% | 0.01% | -14.3% |
| Q2 2022 | $2,882,000 | -16.5% | 74,459 | +23.6% | 0.01% | 0.0% |
| Q1 2022 | $3,452,000 | -30.8% | 60,244 | -3.8% | 0.01% | -30.0% |
| Q4 2021 | $4,992,000 | -61.4% | 62,637 | -57.9% | 0.01% | -61.5% |
| Q3 2021 | $12,935,000 | +443.7% | 148,652 | +704.2% | 0.03% | +420.0% |
| Q2 2021 | $2,379,000 | +70.1% | 18,484 | +5.7% | 0.01% | +66.7% |
| Q1 2021 | $1,399,000 | +0.9% | 17,480 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $1,387,000 | +385.0% | 16,991 | +46.2% | 0.00% | +200.0% |
| Q3 2020 | $286,000 | – | 11,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |